OncoCyte Corp - ESG Rating & Company Profile powered by AI
Browse to the end of the webpage for potential risks for OncoCyte Corp based on sector, geography and size. The dashboard includes a Q&A section about OncoCyte Corp. If you are employed by OncoCyte Corp and you wish to use your ESG aseessment, please contact us.
OncoCyte Corp in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 2.8; made up of an environmental score of 2.0, social score of 4.8 and governance score of 1.6.
2.8
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1353 | Vera Therapeutics Inc | 2.9 | Medium |
| 1353 | Veracyte Inc | 2.9 | Medium |
| 1393 | OncoCyte Corp | 2.8 | Medium |
| 1393 | Bioventix PLC | 2.8 | Medium |
| 1393 | Bolt Biotherapeutics Inc | 2.8 | Medium |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does OncoCyte Corp have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes OncoCyte Corp disclose current and historical energy intensity?
Sign up for free to unlockDoes OncoCyte Corp report the average age of the workforce?
Sign up for free to unlockDoes OncoCyte Corp reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes OncoCyte Corp disclose its ethnicity pay gap?
Sign up for free to unlockDoes OncoCyte Corp disclose cybersecurity risks?
Sign up for free to unlockDoes OncoCyte Corp offer flexible work?
Sign up for free to unlockDoes OncoCyte Corp have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes OncoCyte Corp disclose the number of employees in R&D functions?
Sign up for free to unlockDoes OncoCyte Corp conduct supply chain audits?
Sign up for free to unlockDoes OncoCyte Corp disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes OncoCyte Corp conduct 360 degree staff reviews?
Sign up for free to unlockDoes OncoCyte Corp disclose the individual responsible for D&I?
Sign up for free to unlockDoes OncoCyte Corp disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes OncoCyte Corp disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes OncoCyte Corp disclose water use targets?
Sign up for free to unlockDoes OncoCyte Corp have careers partnerships with academic institutions?
Sign up for free to unlockDid OncoCyte Corp have a product recall in the last two years?
Sign up for free to unlockDoes OncoCyte Corp disclose incidents of discrimination?
Sign up for free to unlockDoes OncoCyte Corp allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas OncoCyte Corp issued a profit warning in the past 24 months?
Sign up for free to unlockDoes OncoCyte Corp disclose parental leave metrics?
Sign up for free to unlockDoes OncoCyte Corp disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes OncoCyte Corp disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes OncoCyte Corp disclose the pay ratio of women to men?
Sign up for free to unlockDoes OncoCyte Corp support suppliers with sustainability related research and development?
Sign up for free to unlockDoes OncoCyte Corp disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes OncoCyte Corp reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs OncoCyte Corp involved in embryonic stem cell research?
Sign up for free to unlockDoes OncoCyte Corp disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes OncoCyte Corp disclose its waste policy?
Sign up for free to unlockDoes OncoCyte Corp report according to TCFD requirements?
Sign up for free to unlockDoes OncoCyte Corp disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes OncoCyte Corp disclose energy use targets?
Sign up for free to unlockDoes OncoCyte Corp disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes OncoCyte Corp have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for OncoCyte Corp
These potential risks are based on the size, segment and geographies of the company.
OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay. It also provides biomarker discovery testing, assay design and development, and clinical trial support services, as well as various biomarker tests for pharmaceutical companies. The company has a collaboration agreement with Life Technologies Corporation to develop and collaborate in the commercialization of Oncomine Comprehensive Assay Plus and Determa IO assay for use with Ion Torrent Genexus integrated sequencer and purification system. OncoCyte Corporation was incorporated in 2009 and is based in Irvine, California.